Studying how people with ALS communicate in conversations
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at how people with ALS and their conversation partners talk with each other. It aims to understand changes in speech and find better ways to support communication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of ALS with some speech changes
- You can say single words clearly enough to be understood
- You are a native speaker of American English
- You have no other conditions like a stroke or memory problems
- You can take a short phone-based memory and thinking test
- You are willing to have your conversations recorded and studied
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how listening to speech during interactive tasks affects what you hear. It may help us understand how people communicate in everyday situations.
This study uses smartphone or computer recordings to find early changes in speech that may help monitor ALS progression. It focuses on Spanish speakers and may help track how the disease affects speaking over time.
This study follows people living with amyotrophic lateral sclerosis (ALS) over time. It may help researchers better understand ALS and track changes that could guide future treatments.
This study looks at how much burden (stress and day-to-day strain) ALS creates for both the patient and the main caregiver. It may help shape better ways to support families facing ALS over time.
This study uses a comprehensive analysis platform to better understand ALS (and related conditions) and help find ways to “remedy and eliminate” it. If you have ALS or are a healthy control who can safely complete questionnaires and possibly an MRI, you may be able to contribute data that researchers use to improve care.
This study continuously measures activity and movement in people with ALS and in control participants. It aims to better understand how muscle disease changes day-to-day function, which may help improve future monitoring or care.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.